(구)글로벌 핫이슈
방사선종양학
- 2017년 10월호[Clin Cancer Res.] A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
Roswell Park Cancer Institute / Jason B. Muhitch*2017 Sep 1댓글: 1조회수: 1337
- 2017년 10월호[Clin Cancer Res.] Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.
Memorial Sloan Kettering Cancer Center / Jeho Jeong*2017 Sep 15댓글: 0조회수: 1259
- 2017년 10월호[Clin Cancer Res.] In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model.
Toronto General Hospital / Marc de Perrot*2017 Sep 15댓글: 0조회수: 1230
- 2017년 10월호[Lancet Oncol.] Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
Universite Paris-Sud / Jean-Pierre Pignon*2017 Sep댓글: 0조회수: 1267
- 2017년 10월호[Lancet Oncol.] First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
University of Oxford / Ricky A Sharma*2017 Sep댓글: 0조회수: 1157
- 2017년 10월호[J Natl Cancer Inst.] Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.
Massachusetts General Hospital / Theodore S. Hong*2017 Sep 1댓글: 0조회수: 1194
- 2017년 09월호[Front Oncol] Radiation Therapy in Extensive Stage Small Cell Lung Cancer.
BioIRC Centre for Biomedical Research / Branislav Jeremic*2017 Aug 11댓글: 1조회수: 1170
- 2017년 09월호[Lancet Oncol.] Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
The Christie NHS Foundation Trust / Corinne Faivre-Finn* 2017 Aug댓글: 0조회수: 1240
- 2017년 09월호[Lancet Oncol.] Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Mayo Clinic / Paul D Brown* 2017 Aug댓글: 0조회수: 1199
- 2017년 09월호[Clin Cancer Res.] A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients.
University of Manchester/ Catharine M.L.*2017 Aug 15댓글: 0조회수: 1176
